Profit Allocation in the Pharma Industry—Who Wants a Slice of the Tax Pie?

; posted on
March 27th, 2018

As many countries are now fully armed to combat corporate tax avoidance, tax authorities have started insistently claiming their ‘‘fair share’’ of tax income. They all are looking at the same profit, yet aiming to get a bigger piece, if not the whole ‘pie’. Facing this perfect tax storm, multinational enterprises should be proactive in determining how the profit is allocated.

This statement is also applicable to multinational pharmaceutical companies illustrated by recent tax cases of Eli Lilly in Brazil (Case number 16561.720001/2011-10), Pfizer in the U.S. (Pfizer Inc. v. D.C. Office of Tax and Revenue, D.C. OAH) and many other similar disputes, as well as the blocking of Pfizer and Allergan merger due to potential tax advantages.

To provide multinationals with a simple tool for high level profit allocation, TPA Global suggest a practical and quantitative approach on how to allocate the profit within a multinational enterprise. This article applies the model on the pharmaceutical industry considering industry trends and market data.

Read the full article

Steef Huibregtse is CEO and Senior Partner and Maria Grigoryeva is an Associate at TPA Global.

We Provide Solutions - Let's Talk Business!

TPA Global Solutions Pack

“One-Stop” Outbound Investment Service to Europe

With the fast growth of China’s economy and the continuous improvement of the comprehensive strength of domestic enterprises, as well as the implementation of the “One Belt, One Road” policy, an increasing amount of Chinese enterprises are beginning to expand their global footprint and establish their presence in Europe.

Introduction   下载手册   Download Leaflet

CFO's Journey from 'Staying Out Of Trouble' to being 'Fully In Control'

TPA Global has developed a practical roadmap of 6 steps meant to guide CFOs in their Journey of rising above troubles to reach a situation of full control. These steps are presented in a series of short video clips (3-5 minutes):

Roadmap for CFO's

Copyright © 2019
Transfer Pricing Associates BV.
All rights reserved.

H.J.E. Wenckebachweg 210
1096 AS Amsterdam
T: +31 20 462 3530